Functional characterization of biodegradable nanoparticles as antigen delivery system

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• Peptide vaccines face challenges with stability and delivery to antigen-presenting cells (APCs).
• Biodegradable nanoparticles (NPs) are explored as antigen carriers to overcome these limitations.
• Cationic poly (D,L-lactide-co-glycolide) and polyethylenimine (PLGA/PEI) NPs are investigated for protein/peptide antigen delivery.

Purpose of the Study:

• To comprehensively characterize PLGA/PEI NPs for biological applications.
• To compare the efficacy of PLGA/PEI NPs against PLGA NPs in antigen delivery.
• To evaluate the potential of these NPs in therapeutic cancer vaccine development.

Main Methods:

• Flow cytometry and confocal laser scanning microscopy (CLSM) for cellular uptake studies.
• Transmission electron microscopy (TEM) for intracellular localization analysis.
• Ex vivo T cell priming experiments using ovalbumin (OVA) antigen and dendritic cells (DCs).

Main Results:

• PLGA/PEI NPs demonstrated significantly higher uptake by human monocytes and mouse hepatoma cells compared to PLGA NPs.
• TEM revealed perinuclear localization for PLGA/PEI NPs and apical localization for PLGA NPs.
• Both NP types utilized clathrin- and caveolin-dependent pathways, forming multivesicular endosomes (MVE).
• PLGA/PEI NPs effectively delivered OVA to immature dendritic cells (imDCs), promoting maturation and differentiation of CD4+ T cells towards a Th1 memory phenotype.
• Soluble OVA failed to induce DC maturation, indicating an intrinsic adjuvanting effect of the NPs.

Conclusions:

• PLGA/PEI NPs offer superior cellular uptake and antigen delivery compared to PLGA NPs.
• These NPs show significant promise as a delivery system for vaccine development, particularly for therapeutic cancer vaccines.
• The observed Th1 response suggests potential for amplifying CD8+ T cell cytotoxic responses.